SIS - Senologic International Society retweetledi
SIS - Senologic International Society
69 posts
SIS - Senologic International Society
@SIS_Breast
The SIS was founded in 1976. Today SIS is a worldwide federation of breast societies, associations and groups related to Breast Care.
Katılım Ocak 2019
1.6K Takip Edilen389 Takipçiler
SIS - Senologic International Society retweetledi
Proud to share our new paper: Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes | SpringerLink #breastcancer link.springer.com/article/10.124…
English
SIS - Senologic International Society retweetledi
Excited to share our long term results of SLYMPHA procedure this time using bio impedance spectroscopy - European Journal of Surgical Oncology #lymphedema #breastcancer ejso.com/article/S0748-…
Aventura, FL 🇺🇸 English
CDK 4/6 inhibitors improves survival in advanced breast cancer patients.... Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a ... - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/3197056…
English
Final overall survival (OS) results from the MONARCH 2 and MONALEESA-3 trials show consistent OS benefits with the cyclin-dependent kinase 4/6(CDK4/6) inhibitors abemaciclib (Verzenio, Lilly) and ribociclib (Kisqali, Novartis). medscape.com/viewarticle/91… via @medscape
English
Orbital Metastasis in Breast Cancer | NEJM nejm.org/doi/full/10.10…
Română
Cosmetic Outcomes Equal After Partial vs Whole Breast Radiation medscape.com/viewarticle/91… via @medscape
English
In the first-line or second-line setting, CDK4/6 inhibitors plus hormone therapies are better than standard hormone therapies in terms of progression-free survival. ncbi.nlm.nih.gov/pubmed/3149403…
English
Adding Ovarian Suppression to Tamoxifen for Premenopausal Patient increases Survival: A Randomized Phase III Trial. - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/3151817…
English
Mammographic screening in High-risk men showed promising results. jwatch.org/FW115836 via @Physns1stWatch
English
Hormone replacement therapy increases breast cancer risk even after 1 year. Combined therapy increases more than estrogen alone... thelancet.com/journals/lance…
English
AI added to the risk reduction guidelines in postmenopausal women. - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/3147930…
English
CCD20 as a predictor to the response to endocrine therapy - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/3147183…
English
Chemotherapy during pregnancy: Other than induced preterm births, there were no serious adverse perinatal outcomes. A population-based perinatal outcome study. - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/3148888…
English
A promising agent to use in Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy: Indocyanine Green Fluorescence... link.springer.com/article/10.124…
English
The end-of-study analysis of the landmark CLEOPATRA trials shows that 37% of patients with HER2-positive metastatic breast cancer are still alive at 8 years. ascopost.com/issues/july-10…
English
6 Months of adjuvant Trastuzumab is noninferior to 12 months in disease free survival!PERSEPHONE: 4-Year Disease-Free Survival With 6 vs 12 Months of Adjuvant Trastuzumab for HER2-Positive Breast Cancer - The ASCO #sis #breastcancer #trastuzumab Post ascopost.com/News/60169?ema…
English
When to start screening for breast cancer after chest irradiation: 25 or 30? cancernetwork.com/article/breast…
English
MONALEESA-7 Shows Overall Survival Benefit for Ribociclib/Endocrine Therapy - The ASCO Post ascopost.com/issues/june-10…
English
No Reason to Stop Mammography Screening at Age 75, Study Suggests medpagetoday.com/reading-room/a…
English